Small intestinal bacterial overgrowth in chronic liver disease: an updated systematic review and meta-analysis of case-control studies
Ayesha Shah(Translational Research Institute), Gerald Holtmann(Royal Adelaide Hospital), Liam Spannenburg(The University of Queensland), Natasha A. Koloski(Princess Alexandra Hospital), Ali Rezaie(Cedars-Sinai Medical Center), Mark Pimentel(Cedars-Sinai Medical Center), Purna Kashyap(Mayo Clinic), Thomas Fairlie(Translational Research Institute), Parag Thite(The University of Queensland), Gregory J. Gores(Mayo Clinic in Arizona), Michael P. Jones(Macquarie University), Mark Morrison(The University of Queensland)
Cited by 9
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k